Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 24, 2013
Theorem Clinical Research, one of the leading CROs in the medical device arena, will be in Boston for the Outsourcing in Clinical Trials New England conference, Oct. 1-2 at the Westin Boston Waterfront in Boston.
read more
Alkermes plc today announced that it has expanded its senior management team by appointing two industry veterans to newly created roles. Srdjan (Serge) Stankovic, M.D., MSPH, will serve as Senior Vice President of Clinical Development and Medical ...
read more
Thursday, October 31, 2013
Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, today announces a three-year extension of its integrated contract drug discovery agreement with Genentech, a member of ...
read more
Thursday, October 31, 2013
Royal DSM, the global Life Sciences and Materials Sciences company, today announced it has signed an agreement with the Sanquin Blood Supply Foundation (Sanquin) for the commercial manufacture of a monoclonal antibody used for the recovery and ...
read more
Monday, November 04, 2013
Almac’s Clinical Services Business Unit is delighted to announce that Richard Segiel, Jr. has joined the company as Vice President of Business Development for the United States. He brings with him 23 successful years of experience in the contract ...
read more
Monday, November 11, 2013
Celerion is pleased to announce the appointment of Clayton Dehn as Executive Director, Metabolic Diseases. Mr. Dehn will lead the expansion of Celerion’s current capabilities that support early Proof-of-Concept in the development of diabetes, obesity...
read more
Monday, November 11, 2013
Exco InTouch, the leading provider of patient engagement and data capture solutions for clinical research and healthcare providers, has been appointed to build an electronic scoring system for the US and International clinical researcher of the year ...
read more
Monday, November 11, 2013
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has received formal approval from the U.S. Food and Drug Administration (FDA) of its supplemental filing for the site transfer of ...
read more
Friday, November 15, 2013
Quotient Clinical – the pioneer of Translational Pharmaceutics™ – has announced a significant expansion of its capacity and capabilities.
read more
Tuesday, November 19, 2013
INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, has unveiled a new brand campaign, “I am INC Research,” that illustrates how the Company keeps customers, ...
read more
Tuesday, November 19, 2013
Clinical research associates earn top honors at PharmaTimes’ industry competition
WILMINGTON, N.C. (November 18, 2013) – Pharmaceutical Product Development, LLC (PPD) today announced that company clinical research associates (CRAs) earned ...
read more
Thursday, November 21, 2013
Pure MHC, LLC, a provider of MHC-based diagnostics and therapeutics, and Catalent Pharma Solutions, the global leader in drug development solutions and advanced delivery technologies for pharmaceutical, biologic and consumer health products, today ...
read more
Thursday, November 21, 2013
The Vietnam Ministry of Health’s Administration of Science, Technology and Training (ASTT) has signed an agreement with Quintiles to enhance clinical research in this rapidly growing nation of 90 million people, Quintiles announced today.
read more
Thursday, November 28, 2013
Catalent Pharma Solutions, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, today announced it has signed an agreement with Pharmacyclics for the oncology drug IMBRUVICA™ (...
read more
Thursday, November 28, 2013
Quotient Clinical – the pioneer of Translational Pharmaceutics™ – has announced a significant expansion of its capacity and capabilities. This investment is a direct response to the rapid rate of adoption of the Company’s Translational Pharmaceutics ...
read more